Cargando…

Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK

INTRODUCTION: Delays in cancer diagnosis arose from the commencement of non-pharmaceutical interventions (NPI) introduced in the UK in March 2020 in response to the COVID-19 pandemic. Our earlier work predicted this will lead to approximately 3620 avoidable deaths for four major tumour types (breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gheorghe, Adrian, Maringe, Camille, Spice, James, Purushotham, Arnie, Chalkidou, Kalipso, Rachet, Bernard, Sullivan, Richard, Aggarwal, Ajay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530528/ https://www.ncbi.nlm.nih.gov/pubmed/34049776 http://dx.doi.org/10.1016/j.ejca.2021.04.019

Ejemplares similares

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
por: Maringe, Camille, et al.
Publicado: (2020)

Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England
por: Fox, Louis, et al.
Publicado: (2022)

Persistent inequalities in unplanned hospitalisation among colon cancer patients across critical phases of their care pathway, England, 2011–13
por: Maringe, Camille, et al.
Publicado: (2018)

Contrasting effects of comorbidities on emergency colon cancer diagnosis: a longitudinal data-linkage study in England
por: Renzi, Cristina, et al.
Publicado: (2019)

Economics of Pediatric Cancer in Four Eastern Mediterranean Countries: A Comparative Assessment
por: Gheorghe, Adrian, et al.
Publicado: (2020)

Capacity for health economics research and practice in Jordan, Lebanon, the occupied Palestinian territories and Turkey: needs assessment and options for development
por: Gheorghe, Adrian, et al.
Publicado: (2020)

Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study
por: Exarchakou, Aimilia, et al.
Publicado: (2018)

Trends in lung cancer emergency presentation in England, 2006–2013: is there a pattern by general practice?
por: Maringe, Camille, et al.
Publicado: (2018)

Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference
por: Maringe, Camille, et al.
Publicado: (2020)

Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort
por: Tran, Thi‐Van‐Trinh, et al.
Publicado: (2021)

Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK
por: Culyer, Anthony J., et al.
Publicado: (2021)

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
por: Culyer, Anthony J., et al.
Publicado: (2019)

Explained variation of excess hazard models
por: Maringe, Camille, et al.
Publicado: (2018)

Comparison of model-building strategies for excess hazard regression models in the context of cancer epidemiology
por: Maringe, Camille, et al.
Publicado: (2019)

Deriving stage at diagnosis from multiple population-based sources: colorectal and lung cancer in England
por: Benitez-Majano, S, et al.
Publicado: (2016)

Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities
por: Maringe, Camille, et al.
Publicado: (2017)

Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study
por: Aggarwal, Ajay, et al.
Publicado: (2017)

Cancer survival differences between South Asians and non-South Asians of England in 1986–2004, accounting for age at diagnosis and deprivation
por: Maringe, C, et al.
Publicado: (2015)

Report on the 1st Indian Cancer Congress 2013
por: Sullivan, Richard, et al.
Publicado: (2013)

Deprivation-specific life tables using multivariable flexible modelling – trends from 2000–2002 to 2010–2012, Portugal
por: Antunes, Luís, et al.
Publicado: (2019)

Achieving high-quality universal health coverage: a perspective from the National Health Service in England
por: Friebel, Rocco, et al.
Publicado: (2018)

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018)

Cancer mortality in ethnic South Asian migrants in England and Wales (1993–2003): patterns in the overall population and in first and subsequent generations
por: Mangtani, P, et al.
Publicado: (2010)

The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
por: Kazibwe, Joseph, et al.
Publicado: (2022)

Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations
por: Rachet, Bernard, et al.
Publicado: (2015)

Data-Adaptive Estimation for Double-Robust Methods in Population-Based Cancer Epidemiology: Risk Differences for Lung Cancer Mortality by Emergency Presentation
por: Luque-Fernandez, Miguel Angel, et al.
Publicado: (2018)

Socioeconomic inequalities in cancer survival in England after the NHS cancer plan
por: Rachet, B, et al.
Publicado: (2010)

Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana
por: Gad, Mohamed, et al.
Publicado: (2020)

Sharing the British National Health Service around the world: a self-interested perspective
por: Chalkidou, Kalipso, et al.
Publicado: (2013)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
por: Teerawattananon, Yot, et al.
Publicado: (2021)

Adjusting for overdispersion in piecewise exponential regression models to estimate excess mortality rate in population-based research
por: Luque-Fernandez, Miguel Angel, et al.
Publicado: (2016)

Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data
por: Maringe, Camille, et al.
Publicado: (2020)

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
por: Benitez Majano, Sara, et al.
Publicado: (2019)

Lockdown is not egalitarian: the costs fall on the global poor
por: Broadbent, Alexander, et al.
Publicado: (2020)

Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
por: Smith, Peter C, et al.
Publicado: (2017)

USA stockpiling of remdesivir: How should the world respond?
por: Dawoud, Dalia, et al.
Publicado: (2020)

Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
por: Towse, Adrian, et al.
Publicado: (2021)

Summarizing and communicating on survival data according to the audience: a tutorial on different measures illustrated with population-based cancer registry data
por: Belot, Aurélien, et al.
Publicado: (2019)

Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development
por: Santatiwongchai, Benjarin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nn1mnq9tvne84ctdu8tu5pgc8j